Dialysis-Related Amyloidosis Treatment Act of 2025 | ChamberLight
Bills · HR 4055
IN COMMITTEE· 119TH CONGRESS
House BillHR 4055Health
Dialysis-Related Amyloidosis Treatment Act of 2025
INTRO JUN 20· LAST ACTION JUN 20
READING
2MIN
COSPONSORS
2BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
Voters should care about this bill because it addresses a significant health issue for a vulnerable population: people on long-term dialysis. Dialysis-related amyloidosis can cause severe health problems, and without specific coverage, patients might struggle to afford or access effective treatments.
If this bill becomes law, it guarantees that Medicare will fully cover these specialized treatments, potentially improving the quality of life and health outcomes for thousands of dialysis patients and reducing their medical expenses. If it doesn't pass, these treatments might remain a financial challenge or difficult to access for many who need them.
KEY PROVISIONS
3AI-extracted
PROVISION 01
Amends the Social Security Act to include treatments for dialysis-related amyloidosis as a covered medical service under Medicare.
This ensures that Medicare beneficiaries suffering from this specific condition can get the necessary treatments.
PROVISION 02
Defines "treatments for dialysis-related amyloidosis" as FDA-approved items or services furnished in a dialysis facility, including adjunct supplies or services.
This clearly outlines what specific treatments will be covered, ensuring medical clarity and appropriate use.
PROVISION 03
Establishes that payment for these treatments will be made separately at 100% of reasonable charges, not bundled into general renal dialysis service payments.
This guarantees full financial coverage for these specialized treatments, reducing out-of-pocket costs for patients.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Voters should care about this bill because it addresses a significant health issue for a vulnerable population: people on long-term dialysis. Dialysis-related amyloidosis can cause severe health problems, and without specific coverage, patients might struggle to afford or access effective treatments.
If this bill becomes law, it guarantees that Medicare will fully cover these specialized treatments, potentially improving the quality of life and health outcomes for thousands of dialysis patients and reducing their medical expenses. If it doesn't pass, these treatments might remain a financial challenge or difficult to access for many who need them.
KEY PROVISIONS
AI-extracted
high
Amends the Social Security Act to include treatments for dialysis-related amyloidosis as a covered medical service under Medicare.
This ensures that Medicare beneficiaries suffering from this specific condition can get the necessary treatments.
med
Defines "treatments for dialysis-related amyloidosis" as FDA-approved items or services furnished in a dialysis facility, including adjunct supplies or services.
This clearly outlines what specific treatments will be covered, ensuring medical clarity and appropriate use.
high
Establishes that payment for these treatments will be made separately at 100% of reasonable charges, not bundled into general renal dialysis service payments.
This guarantees full financial coverage for these specialized treatments, reducing out-of-pocket costs for patients.
A serious medical condition that can affect people on long-term kidney dialysis, where abnormal protein deposits build up in tissues and organs, causing damage.
Medicare
A federal health insurance program for people 65 or older, certain younger people with disabilities, and people with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant).
Social Security Act
A broad law that established the Social Security program and various welfare and health programs, including Medicare.
Renal dialysis services
Medical treatments that remove waste products and excess fluid from the blood when a person's kidneys can no longer do so effectively; commonly referred to as kidney dialysis.
Prospective payment amount
A payment system where Medicare pays a fixed amount for specific services or a group of services, regardless of the actual cost, based on predetermined rates.
FDA-approved
Means that the Food and Drug Administration (FDA) has officially determined that a drug or medical device is safe and effective for its intended use.
Reasonable charges
ACTION TIMELINE
2 EVENTS
JUN 20, 25
Introduced in House
INTROREFERRAL
JUN 20, 25
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
